ArticleNature communications2026
Radical footprinting in mammalian whole blood.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
11 authors.
Funding
Abstract
Hydroxyl Radical Protein Footprinting is a powerful tool to probe protein higher-order structure, protein-protein and protein-ligand interactions. It is mostly performed in vitro, but recent advances have extended its use to live cells, nematodes, and 3D cultures. However, to the best of our knowledge, application in living mammalian tissues has not been accomplished. Here, we present the successful use of radical protein footprinting (RPF) in mammalian whole blood from wild-type and type 2 diabetes mellitus (T2DM) mice. Using persulfate photoactivated with the FOX Photolysis System, we achieve effective protein labeling without significant disruption to blood cell morphology. An optimized quenching protocol eliminates background labeling. We report oxidative modifications for the eleven most abundant proteins detected, revealing disease-associated conformational changes in multiple proteins. We validate that in-blood RPF identifies changes in protein structure resulting from complement activation and increased transferrin iron saturation in T2DM mice. These findings demonstrate the feasibility of RPF in mammalian blood and create opportunities for structural proteomics in preclinical models and clinical samples.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.